0.03
-0.0009(-3.44%)
Currency In USD
Address
2100 East 54th Street North
Sioux Falls, SD 33140
United States of America
Phone
605-679-6980
Sector
Healthcare
Industry
Biotechnology
Employees
63
First IPO Date
October 25, 2021
| Name | Title | Pay | Year Born |
| Mr. Samuel J. Reich | Chief Executive Officer & Executive Chairman | 782,100 | 1975 |
| Ms. Christine E. Hamilton M.B.A. | Co-Founder & Independent Director | 32,000 | 1956 |
| Ms. Lucy To | Executive Vice President & Chief Financial Officer | 165,131 | 1986 |
| Dr. Christoph Bausch M.B.A., Ph.D. | Executive Vice President & Chief Operating Officer | 574,585 | 1971 |
| Dr. Eddie Joe Sullivan Ph.D. | Co-Founder, President & Director | 744,382 | 1967 |
| Dr. Alexandra Kropotova M.B.A., M.D. | Executive Vice President & Chief Medical Officer | 790,150 | 1973 |
| Dr. Edward D. Hamilton D.V.M. | Co-Founder & Board Observer | 0 | N/A |
| Dr. Carlos N. Carillo Ph.D. | Senior Vice President of Regulatory Affairs | 0 | N/A |
SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology. It offers SAB-142 anti-thymocyte globulin for Type 1 diabetes; SAB-176 for seasonal influenza; and SAB-301 for Middle East Respiratory Syndrome Coronavirus (MERS-COV). SAB Biotherapeutics, Inc. was incorporated in 2014 and is based in Sioux Falls, South Dakota with an additional office in Cambridge, Massachusetts.